Turn Therapeutics, Inc. (TTRX)
8.48
-0.16
(-1.85%)
USD |
NASDAQ |
Nov 20, 10:47
Turn Therapeutics Cash from Investing (Quarterly) : -0.0161M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.0161M |
| June 30, 2026 | -0.0058M |
| March 31, 2026 | -0.0122M |
| December 31, 2025 | -0.0314M |
| Date | Value |
|---|---|
| September 30, 2025 | -0.0898M |
| June 30, 2025 | -0.0318M |
| March 31, 2025 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Journey Medical Corp. | 0.00 |
| ANI Pharmaceuticals, Inc. | -13.50M |
| Corcept Therapeutics, Inc. | -131.99M |
| Veru, Inc. | 1.802M |
| Johnson & Johnson | -2.709B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.549M |
| Cash from Financing (Quarterly) | 1.641M |
| Free Cash Flow | -5.347M |
| Free Cash Flow Per Share (Quarterly) | -0.0519 |
| Free Cash Flow to Equity (Quarterly) | -1.676M |
| Free Cash Flow to Firm (Quarterly) | -1.224M |
| Free Cash Flow Yield | -2.07% |